Last reviewed · How we verify

NCT05446584: PATH

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Recruiting now Phase 2 Last updated 4 May 2025
What this trial tests

Phase 2 trial testing High Definition Transcranial Direct Current Stimulation in Mild Cognitive Impairment in 75 participants. Currently enrolling.

Timeline
20 April 2023
Primary endpoint
1 May 2027
31 May 2027

Quick facts

Lead sponsorUniversity of Texas Southwestern Medical Center
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposediagnostic
Enrollment75
Start date20 April 2023
Primary completion1 May 2027
Estimated completion31 May 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas Southwestern Medical Center

Who can join

55 and older, any sex, with Mild Cognitive Impairment or Amnestic Mild Cognitive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those who Do Not have a history of mTBI will be enrolled in the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of High Definition Transcranial Direct Current Stimulation

Trials testing the same drug.

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05446584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing